Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitrectomy | 66 | 2024 | 389 | 11.910 |
Why?
|
Retinal Detachment | 56 | 2024 | 426 | 10.440 |
Why?
|
Endophthalmitis | 25 | 2024 | 263 | 7.090 |
Why?
|
Visual Acuity | 89 | 2024 | 2708 | 5.940 |
Why?
|
Retinal Perforations | 26 | 2022 | 138 | 5.440 |
Why?
|
Eye Injuries, Penetrating | 13 | 2024 | 121 | 5.050 |
Why?
|
Retinal Diseases | 19 | 2023 | 709 | 3.650 |
Why?
|
Epiretinal Membrane | 15 | 2024 | 72 | 3.530 |
Why?
|
Vitreous Body | 18 | 2022 | 400 | 3.380 |
Why?
|
Vitreoretinopathy, Proliferative | 11 | 2024 | 75 | 3.250 |
Why?
|
Eye Foreign Bodies | 9 | 2024 | 51 | 3.220 |
Why?
|
Scleral Buckling | 19 | 2024 | 94 | 2.550 |
Why?
|
Fluorescein Angiography | 36 | 2024 | 1085 | 2.520 |
Why?
|
Intravitreal Injections | 25 | 2024 | 401 | 2.410 |
Why?
|
Diabetic Retinopathy | 25 | 2023 | 1299 | 2.410 |
Why?
|
Macular Edema | 16 | 2023 | 387 | 2.310 |
Why?
|
Tomography, Optical Coherence | 50 | 2024 | 2932 | 2.260 |
Why?
|
Eye Infections, Fungal | 5 | 2018 | 99 | 2.180 |
Why?
|
Retina | 30 | 2023 | 2657 | 2.140 |
Why?
|
Retinal Pigment Epithelium | 9 | 2017 | 310 | 2.110 |
Why?
|
Eye Infections, Bacterial | 9 | 2024 | 239 | 2.010 |
Why?
|
Choroid Diseases | 7 | 2016 | 63 | 1.970 |
Why?
|
Choroid | 8 | 2019 | 363 | 1.930 |
Why?
|
Vitreous Hemorrhage | 6 | 2024 | 47 | 1.880 |
Why?
|
Retinal Vein Occlusion | 9 | 2018 | 149 | 1.740 |
Why?
|
Ophthalmologic Surgical Procedures | 6 | 2024 | 354 | 1.700 |
Why?
|
Angiogenesis Inhibitors | 19 | 2023 | 2056 | 1.560 |
Why?
|
Eye Injuries | 8 | 2019 | 228 | 1.550 |
Why?
|
Retinal Hemorrhage | 7 | 2020 | 98 | 1.420 |
Why?
|
Endotamponade | 8 | 2021 | 37 | 1.350 |
Why?
|
Central Serous Chorioretinopathy | 3 | 2024 | 33 | 1.310 |
Why?
|
Subretinal Fluid | 2 | 2019 | 25 | 1.220 |
Why?
|
Vitreoretinal Surgery | 5 | 2021 | 28 | 1.100 |
Why?
|
Eye Diseases | 5 | 2017 | 659 | 1.100 |
Why?
|
Laser Coagulation | 8 | 2020 | 334 | 1.100 |
Why?
|
Macular Degeneration | 10 | 2022 | 1014 | 1.060 |
Why?
|
Basement Membrane | 7 | 2020 | 349 | 1.000 |
Why?
|
Retinal Vessels | 12 | 2024 | 863 | 0.990 |
Why?
|
Silicone Oils | 4 | 2021 | 22 | 0.990 |
Why?
|
Retinal Vasculitis | 5 | 2017 | 46 | 0.950 |
Why?
|
Iodine | 2 | 2017 | 288 | 0.920 |
Why?
|
Vascular Endothelial Growth Factor A | 20 | 2024 | 3513 | 0.910 |
Why?
|
Macula Lutea | 5 | 2024 | 180 | 0.840 |
Why?
|
Optic Nerve Diseases | 2 | 2017 | 343 | 0.820 |
Why?
|
Fluorocarbons | 7 | 2018 | 497 | 0.780 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2022 | 24 | 0.780 |
Why?
|
Vision, Monocular | 1 | 2022 | 71 | 0.770 |
Why?
|
Vision Disorders | 7 | 2022 | 1087 | 0.720 |
Why?
|
Postoperative Complications | 15 | 2022 | 15747 | 0.710 |
Why?
|
Vision, Binocular | 1 | 2022 | 225 | 0.700 |
Why?
|
Fundus Oculi | 16 | 2024 | 559 | 0.690 |
Why?
|
Cataract Extraction | 6 | 2022 | 464 | 0.670 |
Why?
|
Humans | 203 | 2024 | 765968 | 0.650 |
Why?
|
Optic Disk | 3 | 2020 | 421 | 0.640 |
Why?
|
Indicators and Reagents | 1 | 2020 | 457 | 0.630 |
Why?
|
Electric Injuries | 1 | 2018 | 24 | 0.620 |
Why?
|
Myopia, Degenerative | 1 | 2018 | 14 | 0.620 |
Why?
|
Aicardi Syndrome | 1 | 2018 | 16 | 0.610 |
Why?
|
Surgical Wound Infection | 3 | 2017 | 1543 | 0.610 |
Why?
|
Choroid Hemorrhage | 2 | 2017 | 6 | 0.600 |
Why?
|
Drug Compounding | 1 | 2019 | 235 | 0.590 |
Why?
|
Fibrinolysin | 2 | 2015 | 129 | 0.590 |
Why?
|
Sclera | 3 | 2017 | 189 | 0.580 |
Why?
|
Blast Injuries | 3 | 2024 | 318 | 0.580 |
Why?
|
Pseudallescheria | 1 | 2017 | 3 | 0.580 |
Why?
|
Lighting | 1 | 2020 | 211 | 0.580 |
Why?
|
Coloring Agents | 2 | 2020 | 564 | 0.580 |
Why?
|
Filtering Surgery | 1 | 2017 | 34 | 0.570 |
Why?
|
Hypersensitivity | 2 | 2017 | 1168 | 0.570 |
Why?
|
Middle Aged | 97 | 2024 | 223009 | 0.570 |
Why?
|
Glaucoma | 5 | 2022 | 1194 | 0.570 |
Why?
|
Retrospective Studies | 63 | 2024 | 81514 | 0.560 |
Why?
|
Choroidal Neovascularization | 3 | 2016 | 360 | 0.550 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2207 | 0.540 |
Why?
|
Hypertensive Retinopathy | 1 | 2016 | 4 | 0.530 |
Why?
|
Granuloma, Foreign-Body | 1 | 2016 | 41 | 0.530 |
Why?
|
Vancomycin | 3 | 2017 | 504 | 0.520 |
Why?
|
Povidone-Iodine | 1 | 2016 | 54 | 0.520 |
Why?
|
Drug Users | 1 | 2017 | 134 | 0.510 |
Why?
|
Cornea | 5 | 2022 | 1316 | 0.510 |
Why?
|
Male | 113 | 2024 | 363698 | 0.510 |
Why?
|
Retinal Neurons | 2 | 2014 | 67 | 0.500 |
Why?
|
Leukostasis | 1 | 2015 | 23 | 0.500 |
Why?
|
Angiomatosis | 1 | 2015 | 45 | 0.490 |
Why?
|
Endothelium, Corneal | 1 | 2018 | 212 | 0.490 |
Why?
|
Retinal Dystrophies | 1 | 2016 | 65 | 0.480 |
Why?
|
Anti-Bacterial Agents | 11 | 2022 | 7478 | 0.480 |
Why?
|
Prostheses and Implants | 5 | 2022 | 1273 | 0.480 |
Why?
|
Giant Cell Arteritis | 2 | 2016 | 302 | 0.470 |
Why?
|
Geographic Atrophy | 1 | 2016 | 92 | 0.470 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.470 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2024 | 350 | 0.470 |
Why?
|
Retinal Artery Occlusion | 3 | 2013 | 82 | 0.460 |
Why?
|
Temporal Arteries | 1 | 2015 | 154 | 0.450 |
Why?
|
Infarction | 1 | 2015 | 246 | 0.450 |
Why?
|
Polyps | 1 | 2016 | 200 | 0.450 |
Why?
|
Leukocytosis | 1 | 2015 | 248 | 0.440 |
Why?
|
Retinal Neovascularization | 7 | 2021 | 289 | 0.440 |
Why?
|
Glucocorticoids | 7 | 2018 | 2132 | 0.440 |
Why?
|
Connective Tissue Growth Factor | 2 | 2019 | 91 | 0.440 |
Why?
|
Fibrin | 1 | 2016 | 513 | 0.430 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2013 | 39 | 0.430 |
Why?
|
Syphilis | 1 | 2016 | 243 | 0.430 |
Why?
|
Uveal Diseases | 1 | 2013 | 45 | 0.420 |
Why?
|
Basketball | 1 | 2013 | 43 | 0.420 |
Why?
|
Retinoschisis | 2 | 2023 | 30 | 0.420 |
Why?
|
Spironolactone | 1 | 2016 | 415 | 0.410 |
Why?
|
Ophthalmology | 2 | 2017 | 561 | 0.410 |
Why?
|
Blindness | 6 | 2016 | 586 | 0.410 |
Why?
|
Aged | 69 | 2024 | 171117 | 0.400 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 644 | 0.400 |
Why?
|
Corpus Striatum | 1 | 2018 | 1218 | 0.390 |
Why?
|
Female | 106 | 2024 | 396112 | 0.390 |
Why?
|
Tissue Plasminogen Activator | 1 | 2018 | 1167 | 0.390 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2022 | 660 | 0.390 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 311 | 0.390 |
Why?
|
Staphylococcal Infections | 2 | 2016 | 1393 | 0.390 |
Why?
|
Fluocinolone Acetonide | 1 | 2011 | 38 | 0.370 |
Why?
|
Exanthema | 1 | 2016 | 502 | 0.370 |
Why?
|
Air Bags | 1 | 2011 | 12 | 0.370 |
Why?
|
Anterior Chamber | 3 | 1998 | 194 | 0.370 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1084 | 0.360 |
Why?
|
Firearms | 1 | 2018 | 630 | 0.360 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1162 | 0.360 |
Why?
|
Aniridia | 1 | 2010 | 36 | 0.360 |
Why?
|
Adult | 63 | 2024 | 223044 | 0.360 |
Why?
|
Aphakia | 1 | 2010 | 26 | 0.360 |
Why?
|
Disease Management | 2 | 2020 | 2535 | 0.350 |
Why?
|
Pseudophakia | 2 | 2021 | 60 | 0.350 |
Why?
|
Follow-Up Studies | 32 | 2024 | 39193 | 0.350 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 689 | 0.350 |
Why?
|
Anterior Eye Segment | 2 | 2010 | 144 | 0.340 |
Why?
|
Bacteria | 2 | 2018 | 2209 | 0.340 |
Why?
|
Bioprosthesis | 1 | 2014 | 589 | 0.340 |
Why?
|
Choroid Neoplasms | 1 | 2011 | 175 | 0.330 |
Why?
|
Corneal Diseases | 3 | 2022 | 535 | 0.330 |
Why?
|
Visual Prosthesis | 3 | 2016 | 49 | 0.330 |
Why?
|
Iris | 1 | 2010 | 232 | 0.330 |
Why?
|
Polymers | 1 | 2017 | 1621 | 0.330 |
Why?
|
Klebsiella Infections | 1 | 2011 | 146 | 0.330 |
Why?
|
Melanocytes | 1 | 2013 | 515 | 0.320 |
Why?
|
Risk Assessment | 4 | 2021 | 24282 | 0.310 |
Why?
|
Klebsiella pneumoniae | 1 | 2011 | 253 | 0.310 |
Why?
|
Sutures | 1 | 2010 | 284 | 0.310 |
Why?
|
Fibrinolytic Agents | 2 | 2015 | 2080 | 0.300 |
Why?
|
Trabeculectomy | 2 | 2015 | 174 | 0.300 |
Why?
|
Metals | 1 | 2013 | 710 | 0.300 |
Why?
|
Lens Implantation, Intraocular | 4 | 2017 | 192 | 0.300 |
Why?
|
Fungi | 2 | 2018 | 348 | 0.290 |
Why?
|
Intraocular Pressure | 8 | 2020 | 1304 | 0.280 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 902 | 0.280 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1602 | 0.280 |
Why?
|
Cataract | 3 | 2022 | 837 | 0.280 |
Why?
|
Drug Implants | 3 | 2018 | 230 | 0.270 |
Why?
|
Skin Diseases | 1 | 2015 | 1088 | 0.270 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1348 | 0.270 |
Why?
|
Aged, 80 and over | 23 | 2024 | 59489 | 0.260 |
Why?
|
Suture Techniques | 2 | 2010 | 773 | 0.260 |
Why?
|
Microscopy, Acoustic | 2 | 2019 | 47 | 0.250 |
Why?
|
Recombinant Fusion Proteins | 4 | 2022 | 3737 | 0.250 |
Why?
|
Peptide Fragments | 2 | 2015 | 5125 | 0.250 |
Why?
|
Accidents, Traffic | 1 | 2011 | 818 | 0.240 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6364 | 0.240 |
Why?
|
Recurrence | 5 | 2019 | 8501 | 0.230 |
Why?
|
Urban Population | 1 | 2013 | 2040 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 1 | 2011 | 807 | 0.230 |
Why?
|
Self Mutilation | 1 | 2004 | 57 | 0.220 |
Why?
|
Foreign-Body Migration | 2 | 1998 | 220 | 0.220 |
Why?
|
Receptor, TIE-2 | 1 | 2024 | 183 | 0.220 |
Why?
|
Receptors, Fibroblast Growth Factor | 2 | 2023 | 192 | 0.220 |
Why?
|
Risk Factors | 14 | 2024 | 74840 | 0.220 |
Why?
|
Exudates and Transudates | 3 | 2016 | 173 | 0.220 |
Why?
|
Antibodies, Monoclonal | 3 | 2010 | 9249 | 0.210 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1378 | 0.210 |
Why?
|
Trauma Severity Indices | 2 | 2017 | 479 | 0.210 |
Why?
|
Treatment Outcome | 29 | 2023 | 65188 | 0.210 |
Why?
|
Fovea Centralis | 2 | 2023 | 126 | 0.210 |
Why?
|
Retinitis Pigmentosa | 3 | 2016 | 394 | 0.210 |
Why?
|
Adolescent | 19 | 2024 | 88835 | 0.210 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2023 | 22 | 0.210 |
Why?
|
Young Adult | 14 | 2024 | 59889 | 0.200 |
Why?
|
Osteogenesis Imperfecta | 1 | 2003 | 81 | 0.200 |
Why?
|
Intraoperative Period | 2 | 2021 | 508 | 0.200 |
Why?
|
Aqueous Humor | 4 | 2013 | 152 | 0.200 |
Why?
|
Choroideremia | 1 | 2022 | 27 | 0.200 |
Why?
|
Injections | 4 | 2017 | 840 | 0.200 |
Why?
|
Eye Infections, Viral | 2 | 2020 | 61 | 0.190 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1604 | 0.190 |
Why?
|
Eisenmenger Complex | 1 | 2001 | 26 | 0.190 |
Why?
|
Time Factors | 10 | 2024 | 40065 | 0.190 |
Why?
|
Bacteremia | 2 | 2023 | 989 | 0.190 |
Why?
|
Candida | 1 | 2002 | 172 | 0.190 |
Why?
|
Retinal Degeneration | 2 | 2018 | 413 | 0.180 |
Why?
|
Tourette Syndrome | 1 | 2004 | 400 | 0.180 |
Why?
|
Prednisolone | 4 | 2015 | 324 | 0.180 |
Why?
|
Self Report | 3 | 2017 | 3770 | 0.180 |
Why?
|
Staphylococcus | 2 | 2016 | 145 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1661 | 0.170 |
Why?
|
Emulsions | 2 | 2020 | 150 | 0.170 |
Why?
|
Smoking | 1 | 2017 | 9081 | 0.170 |
Why?
|
Coxsackievirus Infections | 1 | 2020 | 43 | 0.170 |
Why?
|
Ophthalmoscopy | 2 | 2019 | 172 | 0.170 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2019 | 30 | 0.170 |
Why?
|
Enterovirus | 1 | 2020 | 69 | 0.170 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8041 | 0.170 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2022 | 339 | 0.160 |
Why?
|
Myopia | 1 | 2021 | 254 | 0.150 |
Why?
|
Contact Lenses | 1 | 2020 | 137 | 0.150 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 2018 | 77 | 0.150 |
Why?
|
Child, Preschool | 8 | 2024 | 42500 | 0.150 |
Why?
|
Administration, Oral | 3 | 2016 | 4015 | 0.150 |
Why?
|
Quinoxalines | 1 | 2020 | 296 | 0.150 |
Why?
|
Retinal Telangiectasis | 1 | 2018 | 26 | 0.150 |
Why?
|
Postoperative Period | 2 | 2020 | 1816 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3529 | 0.150 |
Why?
|
Silicone Elastomers | 2 | 1999 | 78 | 0.150 |
Why?
|
Haemophilus Infections | 1 | 1998 | 93 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2002 | 531 | 0.140 |
Why?
|
Haemophilus influenzae | 1 | 1998 | 176 | 0.140 |
Why?
|
Prospective Studies | 19 | 2022 | 54802 | 0.140 |
Why?
|
Coloboma | 1 | 2018 | 60 | 0.140 |
Why?
|
Incidence | 6 | 2021 | 21480 | 0.140 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5891 | 0.140 |
Why?
|
Drug Therapy, Combination | 7 | 2015 | 6309 | 0.140 |
Why?
|
Ultrasonography | 4 | 2019 | 5993 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 7 | 2019 | 20659 | 0.130 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 37 | 0.130 |
Why?
|
Laser Therapy | 2 | 2020 | 1108 | 0.130 |
Why?
|
Pigment Epithelium of Eye | 2 | 1997 | 209 | 0.130 |
Why?
|
Phacoemulsification | 2 | 1997 | 151 | 0.130 |
Why?
|
Graves Ophthalmopathy | 1 | 2018 | 135 | 0.130 |
Why?
|
Case-Control Studies | 4 | 2019 | 22223 | 0.130 |
Why?
|
Adrenergic beta-Agonists | 1 | 1997 | 345 | 0.130 |
Why?
|
Fusarium | 2 | 2006 | 50 | 0.130 |
Why?
|
European Union | 1 | 2017 | 157 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 752 | 0.120 |
Why?
|
Prosthesis Implantation | 2 | 2022 | 595 | 0.120 |
Why?
|
Retinal Drusen | 1 | 2016 | 78 | 0.120 |
Why?
|
Visually Impaired Persons | 1 | 2016 | 79 | 0.120 |
Why?
|
Ocular Hypertension | 3 | 2002 | 211 | 0.120 |
Why?
|
Massachusetts | 3 | 2017 | 8875 | 0.120 |
Why?
|
Phospholipids | 1 | 2019 | 776 | 0.120 |
Why?
|
Liposomes | 1 | 2019 | 788 | 0.120 |
Why?
|
Microsurgery | 2 | 2011 | 795 | 0.120 |
Why?
|
Moraxellaceae Infections | 1 | 2015 | 7 | 0.120 |
Why?
|
Methotrexate | 2 | 2023 | 1722 | 0.120 |
Why?
|
Glaucoma, Neovascular | 1 | 2015 | 37 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29922 | 0.120 |
Why?
|
Device Approval | 1 | 2017 | 164 | 0.120 |
Why?
|
Collagen Diseases | 1 | 2015 | 38 | 0.120 |
Why?
|
Vitreous Detachment | 1 | 2015 | 22 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8529 | 0.120 |
Why?
|
Double-Blind Method | 3 | 2015 | 12437 | 0.120 |
Why?
|
Rabbits | 3 | 2024 | 4734 | 0.120 |
Why?
|
Military Personnel | 1 | 2024 | 1252 | 0.120 |
Why?
|
Diagnosis, Differential | 5 | 2018 | 12976 | 0.120 |
Why?
|
New England | 1 | 2017 | 1059 | 0.120 |
Why?
|
Atrophy | 3 | 2023 | 1635 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36532 | 0.110 |
Why?
|
Aptamers, Nucleotide | 1 | 2015 | 163 | 0.110 |
Why?
|
Drug Substitution | 2 | 2015 | 292 | 0.110 |
Why?
|
Haiti | 1 | 2016 | 553 | 0.110 |
Why?
|
Organ Size | 1 | 2019 | 2260 | 0.110 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 246 | 0.110 |
Why?
|
Polymerase Chain Reaction | 4 | 2015 | 6069 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1574 | 0.110 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 57 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 216 | 0.110 |
Why?
|
Optic Atrophies, Hereditary | 1 | 1993 | 27 | 0.110 |
Why?
|
Vision, Low | 1 | 2015 | 162 | 0.110 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3446 | 0.110 |
Why?
|
Child | 10 | 2024 | 80564 | 0.100 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2015 | 615 | 0.100 |
Why?
|
Lenses, Intraocular | 4 | 1999 | 141 | 0.100 |
Why?
|
Sclerostomy | 3 | 2012 | 16 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18293 | 0.100 |
Why?
|
HIV Seronegativity | 1 | 2013 | 209 | 0.100 |
Why?
|
Mycoses | 2 | 2006 | 389 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2024 | 10429 | 0.100 |
Why?
|
Explosions | 1 | 2013 | 106 | 0.100 |
Why?
|
Uveitis | 1 | 2016 | 398 | 0.100 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2015 | 781 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 993 | 0.100 |
Why?
|
Ischemia | 3 | 2023 | 1909 | 0.100 |
Why?
|
Michigan | 1 | 2013 | 328 | 0.100 |
Why?
|
Eye Infections | 1 | 2012 | 63 | 0.100 |
Why?
|
Nanoparticles | 2 | 2024 | 1964 | 0.100 |
Why?
|
Neck Injuries | 1 | 2013 | 162 | 0.100 |
Why?
|
Neck Pain | 1 | 2013 | 190 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 368 | 0.100 |
Why?
|
Sulfur Hexafluoride | 1 | 2011 | 26 | 0.100 |
Why?
|
Trochlear Nerve | 1 | 1991 | 26 | 0.100 |
Why?
|
Mass Casualty Incidents | 1 | 2014 | 178 | 0.090 |
Why?
|
Connective Tissue Diseases | 1 | 2015 | 284 | 0.090 |
Why?
|
History, 20th Century | 1 | 2020 | 2761 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2024 | 12768 | 0.090 |
Why?
|
Fourier Analysis | 1 | 2012 | 434 | 0.090 |
Why?
|
Tachyphylaxis | 1 | 2011 | 54 | 0.090 |
Why?
|
Listeriosis | 1 | 1992 | 146 | 0.090 |
Why?
|
Catheterization | 1 | 2017 | 1425 | 0.090 |
Why?
|
Pupil Disorders | 1 | 1991 | 33 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2015 | 1602 | 0.090 |
Why?
|
ROC Curve | 1 | 2019 | 3620 | 0.090 |
Why?
|
Electrodes, Implanted | 2 | 2015 | 830 | 0.090 |
Why?
|
Rupture | 1 | 2013 | 443 | 0.090 |
Why?
|
Infrared Rays | 1 | 2012 | 246 | 0.090 |
Why?
|
Prolapse | 1 | 2010 | 63 | 0.090 |
Why?
|
Wet Macular Degeneration | 1 | 2013 | 164 | 0.090 |
Why?
|
Polypropylenes | 1 | 2010 | 63 | 0.090 |
Why?
|
Dexamethasone | 1 | 2018 | 1963 | 0.090 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2975 | 0.090 |
Why?
|
Serotyping | 1 | 2011 | 330 | 0.090 |
Why?
|
Bacterial Typing Techniques | 1 | 2011 | 263 | 0.090 |
Why?
|
Copper | 1 | 2013 | 367 | 0.090 |
Why?
|
Fatal Outcome | 2 | 2013 | 1831 | 0.090 |
Why?
|
Paralysis | 1 | 1991 | 248 | 0.080 |
Why?
|
Pyrazoles | 1 | 2020 | 2033 | 0.080 |
Why?
|
Brain Abscess | 1 | 2011 | 118 | 0.080 |
Why?
|
Photochemotherapy | 1 | 2016 | 826 | 0.080 |
Why?
|
Mesencephalon | 1 | 1991 | 338 | 0.080 |
Why?
|
Hyperlipidemias | 1 | 2014 | 770 | 0.080 |
Why?
|
Oculomotor Muscles | 1 | 1993 | 404 | 0.080 |
Why?
|
Arthritis | 1 | 2015 | 677 | 0.080 |
Why?
|
Disease Progression | 4 | 2015 | 13632 | 0.080 |
Why?
|
Nephritis, Hereditary | 1 | 2009 | 78 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 616 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 784 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 838 | 0.080 |
Why?
|
Fibrosis | 3 | 2019 | 2070 | 0.080 |
Why?
|
Eye Diseases, Hereditary | 1 | 2009 | 124 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1759 | 0.070 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26318 | 0.070 |
Why?
|
Acute Disease | 4 | 2012 | 7232 | 0.070 |
Why?
|
Scotoma | 1 | 2009 | 128 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1241 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2021 | 1938 | 0.070 |
Why?
|
Astrocytoma | 1 | 1991 | 772 | 0.070 |
Why?
|
Endocarditis, Bacterial | 1 | 2011 | 434 | 0.070 |
Why?
|
Functional Laterality | 2 | 2011 | 2243 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1657 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4034 | 0.070 |
Why?
|
Medicine | 1 | 2014 | 942 | 0.060 |
Why?
|
Retinopathy of Prematurity | 2 | 2005 | 449 | 0.060 |
Why?
|
Cryosurgery | 1 | 2011 | 479 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2012 | 635 | 0.060 |
Why?
|
Apoptosis | 2 | 2019 | 9514 | 0.060 |
Why?
|
Headache | 1 | 2013 | 1259 | 0.060 |
Why?
|
Paclitaxel | 1 | 2013 | 1728 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3807 | 0.060 |
Why?
|
Conjunctiva | 1 | 2009 | 477 | 0.060 |
Why?
|
Video Recording | 1 | 2010 | 969 | 0.060 |
Why?
|
Infant | 5 | 2018 | 36386 | 0.060 |
Why?
|
Clinical Competence | 1 | 2021 | 4863 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 647 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1259 | 0.060 |
Why?
|
Fungemia | 1 | 2005 | 57 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20124 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12807 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4209 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2680 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2017 | 3584 | 0.060 |
Why?
|
Iron | 1 | 2013 | 1816 | 0.060 |
Why?
|
Endothelial Growth Factors | 2 | 1997 | 680 | 0.060 |
Why?
|
United States | 5 | 2024 | 72903 | 0.060 |
Why?
|
Biopsy | 1 | 2015 | 6763 | 0.050 |
Why?
|
Actins | 3 | 2019 | 2056 | 0.050 |
Why?
|
Fluorouracil | 1 | 2009 | 1648 | 0.050 |
Why?
|
Streptococcus anginosus | 1 | 2023 | 25 | 0.050 |
Why?
|
Lymphokines | 2 | 1997 | 911 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1394 | 0.050 |
Why?
|
Phenylephrine | 1 | 2004 | 292 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2015 | 564 | 0.050 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2004 | 175 | 0.050 |
Why?
|
Epistaxis | 1 | 2004 | 119 | 0.050 |
Why?
|
Ciliary Body | 2 | 2021 | 168 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2018 | 1589 | 0.050 |
Why?
|
Pancreatitis, Chronic | 1 | 2006 | 282 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6499 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11888 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Survival Rate | 1 | 2017 | 12795 | 0.050 |
Why?
|
Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
Microelectrodes | 2 | 2015 | 304 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Hypergammaglobulinemia | 1 | 2002 | 70 | 0.050 |
Why?
|
Panuveitis | 1 | 2002 | 33 | 0.050 |
Why?
|
Postoperative Care | 1 | 2009 | 1470 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3272 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2003 | 312 | 0.050 |
Why?
|
Propionibacterium acnes | 1 | 2022 | 59 | 0.050 |
Why?
|
Blood Viscosity | 1 | 2002 | 125 | 0.050 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2004 | 192 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2005 | 696 | 0.050 |
Why?
|
Nitrous Oxide | 1 | 2002 | 166 | 0.050 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 203 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2002 | 205 | 0.050 |
Why?
|
Ectodermal Dysplasia | 1 | 2002 | 106 | 0.050 |
Why?
|
Debridement | 1 | 2003 | 495 | 0.050 |
Why?
|
Epithelium, Corneal | 1 | 2003 | 246 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2001 | 386 | 0.040 |
Why?
|
Cell Separation | 2 | 2017 | 1718 | 0.040 |
Why?
|
Phlebotomy | 1 | 2001 | 138 | 0.040 |
Why?
|
Pigmentation | 1 | 2021 | 143 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.040 |
Why?
|
Heart Septal Defects | 1 | 2001 | 191 | 0.040 |
Why?
|
Hematocrit | 1 | 2001 | 621 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2017 | 425 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2023 | 2631 | 0.040 |
Why?
|
Eye | 1 | 2023 | 710 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12240 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2022 | 1984 | 0.040 |
Why?
|
DNA, Fungal | 1 | 2000 | 276 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 642 | 0.040 |
Why?
|
Acrylic Resins | 1 | 1999 | 131 | 0.040 |
Why?
|
Neuroglia | 2 | 2011 | 964 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4159 | 0.040 |
Why?
|
Ceftazidime | 1 | 1998 | 57 | 0.040 |
Why?
|
Polymethyl Methacrylate | 1 | 1999 | 126 | 0.040 |
Why?
|
Beclomethasone | 1 | 1997 | 38 | 0.040 |
Why?
|
Environment | 1 | 2024 | 1114 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2792 | 0.040 |
Why?
|
Oxygen | 2 | 2017 | 4241 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1997 | 594 | 0.040 |
Why?
|
Anesthetics, Inhalation | 1 | 2002 | 573 | 0.040 |
Why?
|
Keratins | 1 | 2019 | 498 | 0.040 |
Why?
|
Candidiasis | 1 | 2000 | 371 | 0.030 |
Why?
|
Dependovirus | 1 | 2022 | 721 | 0.030 |
Why?
|
Microvessels | 1 | 2021 | 591 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11022 | 0.030 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2018 | 203 | 0.030 |
Why?
|
Triamcinolone Acetonide | 1 | 1997 | 105 | 0.030 |
Why?
|
Bronchitis | 1 | 1997 | 193 | 0.030 |
Why?
|
Candida albicans | 1 | 2000 | 377 | 0.030 |
Why?
|
Cephalosporins | 1 | 1998 | 200 | 0.030 |
Why?
|
Albuterol | 1 | 1997 | 211 | 0.030 |
Why?
|
Electroretinography | 1 | 2018 | 526 | 0.030 |
Why?
|
Androstadienes | 1 | 1997 | 347 | 0.030 |
Why?
|
Betamethasone | 1 | 1995 | 48 | 0.030 |
Why?
|
Eye Abnormalities | 1 | 1998 | 243 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2002 | 1172 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2858 | 0.030 |
Why?
|
Cell Movement | 2 | 2017 | 5194 | 0.030 |
Why?
|
Visual Perception | 2 | 2012 | 1394 | 0.030 |
Why?
|
Genetic Loci | 1 | 2024 | 2631 | 0.030 |
Why?
|
Drainage | 1 | 2020 | 1179 | 0.030 |
Why?
|
Angiopoietin-1 | 1 | 2015 | 132 | 0.030 |
Why?
|
Reading | 1 | 2018 | 539 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1998 | 452 | 0.030 |
Why?
|
Blister | 1 | 2015 | 90 | 0.030 |
Why?
|
Chronic Disease | 3 | 2014 | 9347 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1154 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8626 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13648 | 0.030 |
Why?
|
Foscarnet | 1 | 2013 | 36 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 476 | 0.030 |
Why?
|
Bombs | 1 | 2014 | 72 | 0.030 |
Why?
|
Glaucoma Drainage Implants | 1 | 2015 | 107 | 0.030 |
Why?
|
Uveitis, Posterior | 1 | 2013 | 45 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2878 | 0.030 |
Why?
|
Optic Nerve | 1 | 1997 | 567 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 833 | 0.030 |
Why?
|
Texas | 1 | 2014 | 410 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 257 | 0.030 |
Why?
|
Optic Atrophy | 1 | 1993 | 78 | 0.030 |
Why?
|
Perioperative Period | 1 | 2014 | 251 | 0.030 |
Why?
|
Suppuration | 1 | 1992 | 61 | 0.030 |
Why?
|
Social Support | 1 | 2023 | 2192 | 0.030 |
Why?
|
Equipment Design | 1 | 2020 | 3481 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 1995 | 514 | 0.020 |
Why?
|
Keratin-8 | 1 | 2011 | 11 | 0.020 |
Why?
|
Scleritis | 1 | 1992 | 96 | 0.020 |
Why?
|
Visual Fields | 1 | 2018 | 1063 | 0.020 |
Why?
|
Chickenpox | 1 | 1992 | 95 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1995 | 457 | 0.020 |
Why?
|
Keratin-18 | 1 | 2011 | 37 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168764 | 0.020 |
Why?
|
Corneal Stroma | 1 | 1992 | 166 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 1991 | 111 | 0.020 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3211 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2006 | 3646 | 0.020 |
Why?
|
Hypertrophy | 1 | 2012 | 559 | 0.020 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 244 | 0.020 |
Why?
|
Sensory Thresholds | 1 | 2012 | 377 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1998 | 1424 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1471 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 1991 | 9071 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1652 | 0.020 |
Why?
|
Rhinitis | 1 | 1997 | 752 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18380 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17533 | 0.020 |
Why?
|
Pedigree | 2 | 1998 | 4526 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2009 | 208 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2105 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2652 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5302 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1617 | 0.020 |
Why?
|
Keratitis | 1 | 1992 | 239 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2013 | 751 | 0.020 |
Why?
|
Pregnancy | 2 | 2016 | 30260 | 0.020 |
Why?
|
Retreatment | 1 | 2010 | 598 | 0.020 |
Why?
|
Pain | 2 | 2019 | 5077 | 0.020 |
Why?
|
Prevalence | 2 | 2023 | 15842 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2023 | 26346 | 0.020 |
Why?
|
Hyperpigmentation | 1 | 2009 | 117 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3181 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2587 | 0.020 |
Why?
|
Orientation | 1 | 2009 | 314 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 753 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2002 | 3733 | 0.020 |
Why?
|
DNA, Viral | 1 | 2013 | 2199 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 415 | 0.020 |
Why?
|
Locomotion | 1 | 2009 | 384 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4274 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4348 | 0.020 |
Why?
|
Amylases | 1 | 2006 | 171 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4335 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 1997 | 754 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1731 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 16047 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81819 | 0.010 |
Why?
|
Lubrication | 1 | 2003 | 22 | 0.010 |
Why?
|
Syndrome | 2 | 2002 | 3271 | 0.010 |
Why?
|
Lipase | 1 | 2006 | 320 | 0.010 |
Why?
|
Immunoenzyme Techniques | 2 | 1997 | 1701 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10729 | 0.010 |
Why?
|
Corneal Edema | 1 | 2003 | 45 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
Viscosity | 1 | 2003 | 334 | 0.010 |
Why?
|
Reoperation | 1 | 1993 | 4294 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1316 | 0.010 |
Why?
|
Tropanes | 1 | 2002 | 47 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 520 | 0.010 |
Why?
|
Retinitis | 1 | 2002 | 36 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16721 | 0.010 |
Why?
|
Parasympatholytics | 1 | 2002 | 89 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2005 | 390 | 0.010 |
Why?
|
Ophthalmic Artery | 1 | 2002 | 56 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 18071 | 0.010 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2005 | 410 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2004 | 482 | 0.010 |
Why?
|
Photophobia | 1 | 2002 | 87 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2006 | 866 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9338 | 0.010 |
Why?
|
Papilledema | 1 | 2002 | 130 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9443 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3050 | 0.010 |
Why?
|
Methylprednisolone | 1 | 2002 | 386 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2016 | 3424 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18973 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41649 | 0.010 |
Why?
|
Pancreatitis | 1 | 2006 | 1087 | 0.010 |
Why?
|
Asthma | 1 | 1997 | 6270 | 0.010 |
Why?
|
Vasculitis | 1 | 2002 | 527 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2229 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1999 | 460 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11641 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1999 | 939 | 0.010 |
Why?
|
Birth Weight | 1 | 2005 | 2121 | 0.010 |
Why?
|
Membranes | 1 | 1996 | 164 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3609 | 0.010 |
Why?
|
Vimentin | 1 | 1997 | 258 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10603 | 0.010 |
Why?
|
Light Coagulation | 1 | 1995 | 72 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2406 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1053 | 0.010 |
Why?
|
Factor VIII | 1 | 1997 | 347 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2033 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13462 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 1999 | 1426 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 1999 | 861 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1995 | 967 | 0.010 |
Why?
|
Herpesvirus 3, Human | 1 | 1992 | 159 | 0.010 |
Why?
|
Lens Subluxation | 1 | 1991 | 23 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1995 | 14751 | 0.000 |
Why?
|